跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Daratumumab Injection
Approved
生物制品
Daratumumab Injection
Janssen-Cilag AG
🇨🇳 National Medical Products Administration
Approval Date
Jul 4, 2019
Approval ID
7uctI8W6O8f
Company
Janssen-Cilag AG
Type
生物制品
Approval Details
Approval Id
7uctI8W6O8f
Approval Number
S20190029
Generic Name
达雷妥尤单抗注射液
Generic Name En
Daratumumab Injection
Trade Name
兆珂
Brand Name
兆珂
Drug Type
生物制品
Dosage Form
注射剂
Strength
100mg/5ml/瓶
Reg Date
2019-07-04
Expired Date
2024-07-03
Company Name
Janssen-Cilag AG
Company Address
Gubelstrasse 34 6300 Zug Switzerland
Production Company Name
Cilag AG
Production Company Address
Hochstrasse 201,8200 Schaffhausen, Switzerland
Company Detail Path
/organization/janssen-cilag-ag
Production Company Detail Path
/organization/cilag-ag
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 4, 2019
Approval ID
7uctI8W6O8f
Type
生物制品
Back to NMPA Approvals
兆珂 - NMPA Drug Approval Details